Park Square Financial Group, LLC

Position in EXEL — Exelixis, Inc.

CIK 2058285 ROSWELL, GA

Position in EXEL

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$4,080

-$1,924 QoQ

Shares Held

-46.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#696

of 751 holders

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Park Square Financial Group, LLC holds $11,999 across 3 Biotechnology names. EXEL ranks #2 (34.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	119	$6,672
2	EXEL	Exelixis, Inc. This page	75	$4,080
3	REGN	Regeneron Pharmaceuticals, Inc.	2	$1,247

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,080	75	-46.4%	Shares	Sole	2026-07-31
2026-03-31	$6,004	140	+45.8%	Shares	Sole	2026-05-13
2025-09-30	$3,964	96	-52.0%	Shares	Sole	2025-11-12
2025-06-30	$8,816	200	—	Shares	Sole	2025-08-12
No filing history on record for this holder in this stock.